Functional monocyte chemoattractant protein-1 promoter-2518 polymorphism and systemic lupus erythematosus: a meta-analysis
- Authors
- Lee, Young Ho; Woo, Jin-Hyun; Choi, Sung Jae; Ji, Jong Dae; Song, Gwan Gyu
- Issue Date
- Oct-2010
- Publisher
- SPRINGER
- Keywords
- MCP-1; Polymorphism; Systemic lupus erythematosus; Meta-analysis
- Citation
- MOLECULAR BIOLOGY REPORTS, v.37, no.7, pp.3421 - 3426
- Indexed
- SCIE
SCOPUS
- Journal Title
- MOLECULAR BIOLOGY REPORTS
- Volume
- 37
- Number
- 7
- Start Page
- 3421
- End Page
- 3426
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/115566
- DOI
- 10.1007/s11033-009-9932-5
- ISSN
- 0301-4851
- Abstract
- The monocyte chemoattractant protein-1 (MCP-1) promoter -2518 A/G polymorphism has been reported inconsistently to be associated with systemic lupus erythematosus (SLE) and lupus nephritis (LN). The aim of this study was to explore whether the MCP-1 polymorphism confers susceptibility to SLE or LN. We surveyed studies on the MCP-1 polymorphism and SLE or LN identified by MEDLINE or manual searches. Meta-analysis was conducted on the AA genotype (recessive effect), AA, and AG genotypes (dominant effect), AA versus GG (genotype contrast), and on the A allele of MCP-1 in SLE and LN in each ethnic population studied and on all subjects. Ten studies, which included 1,739 SLE patients and 1,680 controls, were included in our meta-analysis. These consisted of two European, six Asian, one Latin American, and one mixed study. We did not find any association between the MCP-1 -2518 A/G polymorphism and SLE in all subjects or in ethnic groups. Meta-analysis also failed to reveal an association between the MCP-1 -2518 A/G polymorphisms and LN. This meta-analysis on 3419 subjects indicates that no association exists between the MCP-1 -2518 A/G polymorphism and SLE or LN.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.